Nobiletin Improves D-Galactose-Induced Aging Mice Skeletal Muscle Atrophy by Regulating Protein Homeostasis
Nutrients · 07.04.2023 · 15 (8) · 1801
DOI: 10.3390/nu15081801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 07.04.2023. Verfasst von Hui-Hui Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100083, China. Hauptthemen laut MEDLINE: Galactose, Sarcopenia. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Education Ministry of China, 111 project of the Education Ministry of China.
Abstract (Originalsprache)
Sarcopenia, a decrease in skeletal muscle mass and function caused by aging, impairs mobility, raises the risk of fractures, diabetes, and other illnesses, and severely affects a senior’s quality of life. Nobiletin (Nob), polymethoxyl flavonoid, has various biological effects, such as anti-diabetic, anti-atherogenic, anti-inflammatory, anti-oxidative, and anti-tumor properties. In this investigation, we hypothesized that Nob potentially regulates protein homeostasis to prevent and treat sarcopenia. To investigate whether Nob could block skeletal muscle atrophy and elucidate its underlying molecular mechanism, we used the D-galactose-induced (D-gal-induced) C57BL/6J mice for 10 weeks to establish a skeletal muscle atrophy model. The findings demonstrated that Nob increased body weight, hindlimb muscle mass, lean mass and improved the function of skeletal muscle in D-gal-induced aging mice. Nob improved myofiber sizes and increased skeletal muscle main proteins composition in D-gal-induced aging mice. Notably, Nob activated mTOR/Akt signaling to increase protein synthesis and inhibited FOXO3a-MAFbx/MuRF1 pathway and inflammatory cytokines, thereby reducing protein degradation in D-gal-induced aging mice. In conclusion, Nob attenuated D-gal-induced skeletal muscle atrophy. It is a promising candidate for preventing and treating age-associated atrophy of skeletal muscles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100083, China.
- College of Food Science and Engineering, Gansu Agricultural University, Lanzhou 730070, China.
- Food Laboratory of Zhongyuan, Luohe 462000, China.
ORCID-Profile: Peng-Cheng Wen
Förderung
- the Education Ministry of China
- 111 project of the Education Ministry of China
Zitieren
APA
Wang, H. H., Zhang, Y., Qu, T. Q., Sang, X. Q., Li, Y. X., Ren, F. Z., Wen, P. C., & Sun, Y. N. (2023). Nobiletin Improves D-Galactose-Induced Aging Mice Skeletal Muscle Atrophy by Regulating Protein Homeostasis. Nutrients, 15(8), 1801. https://doi.org/10.3390/nu15081801
Vancouver
Wang HH, Zhang Y, Qu TQ, Sang XQ, Li YX, Ren FZ, et al. Nobiletin Improves D-Galactose-Induced Aging Mice Skeletal Muscle Atrophy by Regulating Protein Homeostasis. Nutrients. 2023;15(8):1801. doi:10.3390/nu15081801
BibTeX
@article{Wang2023,
author = {Wang, Hui-Hui and Zhang, Yan and Qu, Tai-Qi and Sang, Xue-Qin and Li, Yi-Xuan and Ren, Fa-Zheng and Wen, Peng-Cheng and Sun, Ya-Nan},
title = {Nobiletin Improves D-Galactose-Induced Aging Mice Skeletal Muscle Atrophy by Regulating Protein Homeostasis},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {8},
pages = {1801},
doi = {10.3390/nu15081801}
}
EUVIMED